κBキナーゼβ阻害体の結晶構造
Guozhou Xu1, Yu-Chih Lo, Qiubai Li
1Department of Biochemistry, Weill Cornell Medical College, New York, New York 10021, USA.
Nature
|March 23, 2011
まとめ
Inhibitor of κB (IκB) キナーゼβ (IKKβ) の結晶構造は,三模様構造を示しています. この構造は,IKKββにとって極めて重要です.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- 分子生物学は分子生物学である.
背景:
- κB (IκB) キナーゼ (IKK) の阻害剤は,核因子 κB (NF-κB) 信号伝達の調節に不可欠である.
- NF-κB転写因子は,免疫と炎症に関与する遺伝子発現を制御する.
- IKKの構造を理解することは,ターゲットを絞った治療法の開発の鍵です.
研究 の 目的:
- IKKβの結晶構造を阻害剤との複合体で決定する.
- IKKβ機能と基板特異性の構造的基礎を解明する.
- IKKβの活動と活性化における異なる領域の役割を調査する.
主な方法:
- X線結晶グラフィーです.
- 3.6 Åの解像度でタンパク質構造の決定
- ドメイン機能の評価のための生化学的測定法
主要な成果:
- IKKβの結晶構造は,キナーゼ領域 (kinase domain),ユビキチン類似領域 (ubiquitin-like domain, ULD),およびスキャフォールド/ダイメリゼーション領域 (scaffold/dimerization domain, SDD) となる三模様構造を明らかにしている.
- ULDとSDDはIκBαと相互作用し,基質の特異性を制限し,触媒的活動を可能にします.
- SDDはIKKβ二分化を媒介し,これは基礎活性ではなく活性化にとって重要である.
結論:
- IKKβは,その機能に不可欠なユニークな三模様構造を有しています.
- ULDとSDDは,基質認識と触媒活動において重要な役割を果たします.
- IKKβの二分化はその活性化の前提条件であり,規制メカニズムを示唆している.
さらに関連する動画
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
13:02Production, Crystallization, and Structure Determination of the IKK-binding Domain of NEMO
Published on: December 28, 2019
関連する概念動画
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
